← Back
$ROIV All transactions

Roivant Sciences Ltd.

F

$ Value

$1K

Shares

115

Price

$12

Filed

Jul 21

Insider

Name

Oren Ilan

Title

CIK

0001643073

Roles

Director

Transaction Details

Transaction Date

2025-04-17

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,681

Footnotes

Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. | Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.

Filing Info

Accession No.

0001140361-25-026649

Form Type

4

Issuer CIK

0001635088

Oren Ilan's History

Date Ticker Type Value
2026-04-17 ROIV A $0
2026-04-17 ROIV F $3K
2025-04-17 ROIV A $0
2025-04-17 ROIV F $1K

Other Insiders at ROIV (90d)

Insider Bought Sold Last
MOMTAZEE JAMES C 2026-04-17
Fitzgerald Meghan $1.9M 2026-03-26
Oren Ilan 2026-04-17
Torti Frank
President and Vant Chair
2026-03-31
Sukhatme Mayukh
President & CIO
2026-03-31
Gline Matthew
CEO
$8.4M 2026-04-16
Venker Eric
President & Immunovant CEO
$5.9M 2026-04-20
Epperly Melissa B, 2026-04-17
Pulik Richard
CFO
2026-04-20
Humes Jennifer
Chief Accounting Officer
$384K 2026-04-20